By Akani Nkuna
President Cyril Ramaphosa on Friday launched the long-acting HIV prevention injection Lenacapavir in Secunda, Mpumalanga, describing it as a major scientific breakthrough in South Africa’s fight against HIV/AIDS.
The injectable drug, administered twice a year, is expected to strengthen HIV prevention efforts by reducing adherence barriers associated with daily medication.
Speaking at the launch, Ramaphosa said Lenacapavir represented a turning point in the country’s response to HIV.
“The launch today marks a turning point in our nation’s fight against HIV. To us, this treatment is not just medicine. It represents one of the most significant scientific breakthroughs since the advent of antiretroviral treatment,” he said.
He described the drug as a triumph of science and innovation that could help save lives, particularly among young women who continue to bear a disproportionate burden of HIV infections.
Ramaphosa said Lenacapavir would strengthen prevention efforts by giving people greater choice
You’ve reached your free article limit
Subscribe to enjoy unlimited access to trusted journalism. Cancel anytime.
Subscribe nowNeed help? molokom@insideeducation.co.za
